- What’s new in medical renal pathology 2025: Updates on podocytopathy and immunofluorescence staining in medical kidney
-
Astrid Weins, Ibrahim Batal, Paola Romagnani, Geetika Singh, Rahul Raj, Nicole Andeen, Jonathan Zuckerman, Martina Uzzo, Mariam Priya Alexander, Anjali Satoskar
-
Received May 22, 2025 Accepted June 18, 2025 Published online May 26, 2025
-
DOI: https://doi.org/10.4132/jptm.2025.06.19
-
-
 Abstract
- Diffuse podocytopathy, including minimal change disease and primary focal segmental glomerulosclerosis, is a common cause of nephrotic syndrome in adults and children. It is increasingly recognized to be autoimmune-mediated associated with anti-nephrin and other emerging anti-slit diaphragm antibodies, and can recur in the kidney allograft. Immunofluorescence is routinely used in evaluation of kidney biopsies, and updates include those on fibrillar diseases, monoclonal staining, lupus-like staining, and use of antibody KM55 in IgA-dominant glomerulonephritis.
|
E-submission
